AAAAAA

   
Results: 1-12 |
Results: 12
SAFETY AND IMMUNOGENICITY OF AN INACTIVATED SUBUNIT INFLUENZA-VIRUS VACCINE COMBINED WITH MF59 ADJUVANT EMULSION IN ELDERLY SUBJECTS, IMMUNIZED FOR 3 CONSECUTIVE INFLUENZA SEASONS
Authors: MINUTELLO M SENATORE F CECCHINELLI G BIANCHI M ANDREANI T PODDA A CROVARI P
Citation: M. Minutello et al., SAFETY AND IMMUNOGENICITY OF AN INACTIVATED SUBUNIT INFLUENZA-VIRUS VACCINE COMBINED WITH MF59 ADJUVANT EMULSION IN ELDERLY SUBJECTS, IMMUNIZED FOR 3 CONSECUTIVE INFLUENZA SEASONS, Vaccine, 17(2), 1999, pp. 99-104
THE MURINE CD30 ANTIGEN MEDIATES THYMOCYTE APOPTOSIS THROUGH A BCL-2 DEPENDENT PATHWAY
Authors: CHIARLE R PODDA A PROLLA G PODACK ER THORBECKE GJ INGHIRAMI G
Citation: R. Chiarle et al., THE MURINE CD30 ANTIGEN MEDIATES THYMOCYTE APOPTOSIS THROUGH A BCL-2 DEPENDENT PATHWAY, Modern pathology, 11(1), 1998, pp. 126-126
CD30 MEDIATES THYMIC PROGRAMMED CELL-DEATH (PCD) THROUGH A BCL-2 SENSITIVE PATHWAY
Authors: CHIRALE R PODDA A PROLLA G PODACK ER THORBECKE GJ INGHIRAMI G
Citation: R. Chirale et al., CD30 MEDIATES THYMIC PROGRAMMED CELL-DEATH (PCD) THROUGH A BCL-2 SENSITIVE PATHWAY, The FASEB journal, 12(5), 1998, pp. 5386-5386
DOES THE MENOPAUSE PLAY A ROLE AS RISK FACTOR FOR ESSENTIAL ARTERIAL-HYPERTENSION
Authors: MERCURO G PITZALIS L PODDA A ZONCU S MASCIA M MELIS G
Citation: G. Mercuro et al., DOES THE MENOPAUSE PLAY A ROLE AS RISK FACTOR FOR ESSENTIAL ARTERIAL-HYPERTENSION, Circulation, 98(17), 1998, pp. 4534-4534
SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/
Authors: BLACK SB SHINEFIELD HR BERGEN R HART C KREMERS R LAVETTER A LEMESURIER J MOROZUMI PA RAY P LEWIS EM FIREMAN B SCHWALBE J HALLAM P SHANDLING M DEKKER C GRANOFF DM IZU A PODDA A
Citation: Sb. Black et al., SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/, The Pediatric infectious disease journal, 16(1), 1997, pp. 53-58
ACELLULAR PERTUSSIS VACCINES CONTAINING GENETICALLY DETOXIFIED PERTUSSIS TOXIN INDUCE LONG-LASTING HUMORAL AND CELLULAR-RESPONSES IN ADULTS
Authors: DITOMMASO A BARTALINI M PEPPOLONI S PODDA A RAPPUOLI R DEMAGISTRIS MT
Citation: A. Ditommaso et al., ACELLULAR PERTUSSIS VACCINES CONTAINING GENETICALLY DETOXIFIED PERTUSSIS TOXIN INDUCE LONG-LASTING HUMORAL AND CELLULAR-RESPONSES IN ADULTS, Vaccine, 15(11), 1997, pp. 1218-1224
ACELLULAR PERTUSSIS-VACCINE IN CHILDREN WITH PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS-TYPE-1 INFECTION
Authors: DEMARTINO M PODDA A GALLI L SINANGIL F MANNELLI F ROSSI ME VIERUCCI A
Citation: M. Demartino et al., ACELLULAR PERTUSSIS-VACCINE IN CHILDREN WITH PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS-TYPE-1 INFECTION, Vaccine, 15(11), 1997, pp. 1235-1238
SAFETY AND IMMUNOGENICITY OF A RECOMBINAN T PERTUSSIS-VACCINE IN PREMATURE AND TERM INFANTS
Authors: PISTILLI AMC REGOLI D PODDA A CARLUCCI F VALLETTI F DELUCA EC
Citation: Amc. Pistilli et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINAN T PERTUSSIS-VACCINE IN PREMATURE AND TERM INFANTS, Rivista italiana di pediatria, 21(2), 1995, pp. 221-228
THE EFFECT OF DTP OR DTAP PRIMING ON THE SAFETY AND IMMUNOGENICITY OFA BOOSTER DOSE OF A RECOMBINANT DTAP VACCINE IN 15 TO 21-MONTH-OLD CHILDREN
Authors: PODDA A RAPPOULI R GRANOFF DM
Citation: A. Podda et al., THE EFFECT OF DTP OR DTAP PRIMING ON THE SAFETY AND IMMUNOGENICITY OFA BOOSTER DOSE OF A RECOMBINANT DTAP VACCINE IN 15 TO 21-MONTH-OLD CHILDREN, Pediatric research, 37(4), 1995, pp. 186-186
EFFECT OF PRIMING WITH DIPHTHERIA AND TETANUS TOXOIDS COMBINED WITH WHOLE-CELL PERTUSSIS-VACCINE OR WITH ACELLULAR PERTUSSIS-VACCINE ON THESAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF AN ACELLULAR PERTUSSIS-VACCINE CONTAINING A GENETICALLY INACTIVATED PERTUSSIS TOXIN IN 15-MONTH-OLD TO 21-MONTH-OLD CHILDREN
Authors: PODDA A BONA G CANCIANI G PISTILLI AMC CONTU B FURLAN R MELONI T STRAMARE D TITONE L RAPPUOLI R GRANOFF DM BARTALINI M BUDRONI M DELUCA EC CASCIO A CASCIO G COSSU M ORTO PD DILEO G DIPISA F FURLAN A MACAGNO F MARSILI I MAIDA A MELONI G MOIRAGHI A NENCIONI L PEPPOLONI S REGOLI D RIGO G TRAPPAN A UXA F VARGIU G VOLPINI G
Citation: A. Podda et al., EFFECT OF PRIMING WITH DIPHTHERIA AND TETANUS TOXOIDS COMBINED WITH WHOLE-CELL PERTUSSIS-VACCINE OR WITH ACELLULAR PERTUSSIS-VACCINE ON THESAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF AN ACELLULAR PERTUSSIS-VACCINE CONTAINING A GENETICALLY INACTIVATED PERTUSSIS TOXIN IN 15-MONTH-OLD TO 21-MONTH-OLD CHILDREN, The Journal of pediatrics, 127(2), 1995, pp. 238-243
COMPARATIVE-STUDY OF A WHOLE-CELL PERTUSSIS-VACCINE AND A RECOMBINANTACELLULAR PERTUSSIS-VACCINE
Authors: PODDA A DELUCA EC CONTU B FURLAN R MAIDA A MOIRAGHI A STRAMARE D TITONE L UXA F DIPISA F PEPPOLONI S NENCIONI L RAPPUOLI R BARTALINI M BONA G BUDRONI M PISTILLI AMC CASCIO A CASCIO G COSSU M DALLORTO P DILEO G FURLAN A MACAGNO F MARSILI I MELONI T REGOLI D RIGO G TRAPPAN A VARGIU G VOLPINI G
Citation: A. Podda et al., COMPARATIVE-STUDY OF A WHOLE-CELL PERTUSSIS-VACCINE AND A RECOMBINANTACELLULAR PERTUSSIS-VACCINE, The Journal of pediatrics, 124(6), 1994, pp. 921-926
IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERTACTIN IN INFANTS AND CHILDREN
Authors: PODDA A DELUCA EC TITONE L CASADEI AM CASCIO A BARTALINI M VOLPINI G PEPPOLONI S MARSILI I NENCIONI L RAPPUOLI R
Citation: A. Podda et al., IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS-VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERTACTIN IN INFANTS AND CHILDREN, The Journal of pediatrics, 123(1), 1993, pp. 81-84
Risultati: 1-12 |